Prenatal diagnosis of smith–lemli–opitz syndrome is possible by measurement of 7-dehydrocholesterol in amniotic fluid |
| |
Authors: | L. Dallaire MD G. Mitchell R. Giguère F. Lefebvre S. B. Melançon M. Lambert |
| |
Affiliation: | 1. Service de Génétique Médicale, Hǒpital Sainte-Justine, Montréal;2. Service de Génétique, Centre Hospitalier Universitaire de Sherbrooke;3. Service de Néonatalogie, Hǒpital Sainte-Justine, Montréal, Québec, Canada |
| |
Abstract: | Amniocentesis was performed at 17.3 weeks in a pregnancy with severe intrauterine growth retardation. Cytogenetic studies on amniocytes were normal, 46,XX, and the pregnancy was continued. The diagnosis of Smith–Lemli–Opitz syndrome was suspected in the neonatal period and confirmed by the presence of 7-dehydrocholesterol (7-DHC) in the plasma (0.4 mmol/l, normal = not detectable) associated with a low total cholesterol concentration (0.4 mmol/l, normal = 2.56 ± 0.23). Retrospective analysis of the amniotic fluid sample revealed an elevated level of 7-DHC (0.022 mmol/l; normal = undetectable). Therefore measurement of 7-DHC levels in amniotic fluid during the second trimester of pregnancy is useful for the prenatal diagnosis of Smith–Lemli–Opitz syndrome in families at risk and should be considered in cases of severe growth retardation of unknown aetiology for which amniotic fluid is available and in which a normal chromosomal pattern in amniocytes is present. |
| |
Keywords: | Smith–Lemli–Opitz syndrome cholesterol amniotic fluid 7-dehydrocholesterol prenatal diagnosis intrauterine growth retardation |
|
|